Merck: Bullish Setup Into Q1 Earnings [Seeking Alpha]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Seeking Alpha
I again expect strong performance from Keytruda and Winrevair. However, in the report itself, I believe the defining moment will be MRK's sales of Keytruda Qlex, whose main role is to offset the launch of biosimilars to Keytruda from 2028. One of the key catalysts I highlight for MRK is the potential FDA approval of Keytruda Qlex+Padcev on August 17 for the treatment of patients with MIBC who are cisplatin-eligible. And further, I'll discuss other factors that, in my view, make MRK stock's risk/reward profile attractive even in the current geopolitical environment. Edwin Tan/E+ via Getty Images So, I am here again, with my analysis of Merck & Co., Inc. ( MRK In my previous article Merck: Why Investors Should Remain Bullish Despite Patent Risks, " I discussed why the
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Sun Pharma to acquire Organon in $11.75 billion deal [Yahoo! Finance]Yahoo! Finance
- Sun Pharma to acquire Organon for $11.75bn [Yahoo! Finance]Yahoo! Finance
- Merck Advances Terns Deal And Cardiovascular And RSV Growth Options [Yahoo! Finance]Yahoo! Finance
- Merck & Co. Inc. (MRK): One of the Best Low Risk High Growth Stocks to Buy Right Now [Yahoo! Finance]Yahoo! Finance
- Summers Value Partners Q4 2025 Partner Letter [Seeking Alpha]Seeking Alpha
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 4/8/26 - Form ARS
- 4/8/26 - Form DEFA14A
- 4/8/26 - Form DEF
- MRK's page on the SEC website